摘要
动脉粥样硬化是动脉粥样硬化斑块在动脉壁中发展的慢性血管疾病。相信炎症在动脉粥样硬化形成和进展中起主要作用。因此,动脉粥样硬化可以被认为是动脉血管的炎性疾病。小鼠模型证实T和B细胞缺乏可减少动脉粥样硬化病变形成中的动脉粥样硬化负担。 CD4 + T辅助细胞(Th),例如已知为动脉粥样硬化发生的小鼠模型中发现的主要CD4 + T细胞亚型的Th1细胞,增加oxLDL引起的斑块形成。 IL-17(也称为IL-17A)由T细胞或T辅助细胞的独特子集产生。产生IL-17的T细胞表达干扰素-γ(IFN-γ),这是免疫功能的重要调节因子,其在动脉粥样硬化病变中高度表达,抵抗了其作为Th17细胞的整齐特征。 Th17信号通路的调控可能在多发性和自身免疫性疾病如动脉粥样硬化的发病机制中起重要作用。在本综述中,描述了IL-17家族的结构特征及其与动脉粥样硬化有关的作用。
关键词: 动脉粥样硬化,斑块,小鼠模型,IL-17,脂蛋白,免疫功能,Th17细胞。
Current Medicinal Chemistry
Title:The Impact of IL-17 in Atherosclerosis
Volume: 24 Issue: 21
关键词: 动脉粥样硬化,斑块,小鼠模型,IL-17,脂蛋白,免疫功能,Th17细胞。
摘要: Atherosclerosis is a chronic vascular disease in which atherosclerotic plaques develop in the arterial wall. It is believed that inflammation plays a major role in atherosclerotic formation and progression. Thus, atherosclerosis can be considered as an inflammatory disease of the arterial vessel. Mouse model demonstrated that T and B cell deficiency reduces the atherosclerotic burden in the formation of an atherosclerotic lesion. CD4+ T helper cells (Th), such as Th1 cells known being the major CD4+ T cell subtype found in mouse models of atherogenesis, increase plaque formation caused by oxLDL. IL-17 (also known as IL-17A) was produced by T cells or by a unique subset of T helper cells. IL-17-producing T cells express interferon- gamma (IFN-γ), an important regulator of immune function, which is highly expressed in atherosclerotic lesions, defying their neat characteristics as Th17 cells. Regulation of Th17 signal pathway may play a significant role in the pathogenesis of multiple inflammatory and autoimmune disorders, such as atherosclerosis. In this review, the structural features of IL-17 family and their roles involved in atherosclerosis are described.
Export Options
About this article
Cite this article as:
The Impact of IL-17 in Atherosclerosis, Current Medicinal Chemistry 2017; 24 (21) . https://dx.doi.org/10.2174/0929867324666170419150614
DOI https://dx.doi.org/10.2174/0929867324666170419150614 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Plasminogen Activator Inhibitor-1: Role in Cell Signaling and the Biology of Domain-Specific Knock-in Mice
Current Drug Targets Immune System Alterations by Aldosterone During Hypertension: From Clinical Observations to Genomic and Non-Genomic Mechanisms Leading to Vascular Damage
Current Molecular Medicine ErbB4 and its Isoforms: Patentable Drug Targets?
Recent Patents on DNA & Gene Sequences The Prostaglandin Agonist Beraprost Aggravates Doxorubicin-mediated Apoptosis by Increasing iNOS Expression in Cardiomyocytes
Current Vascular Pharmacology Gene Therapy Targeting Inflammation in Atherosclerosis
Current Pharmaceutical Design CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?
Cardiovascular & Hematological Disorders-Drug Targets Food and Food Supplements with Hypocholesterolemic Effects
Recent Patents on Food, Nutrition & Agriculture Peptidomimetics - Antagonists of the Fibrinogen Receptors: Molecular Design, Structures, Properties and Therapeutic Applications
Current Medicinal Chemistry New Approaches in the Diagnosis of Atherosclerosis and Treatment of Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Regulation of Cholesterol Biosynthesis and Absorption: Ultimate Management of Dyslipidemia with Statin and Ezetimibe
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Old And New Oral Anticoagulants In Management Of Atrial Fibrillation: A Double-Edged Sword For Women
Current Vascular Pharmacology Breastfeeding and Diabetes
Current Diabetes Reviews Serine Protease Inhibitors and T Lymphocyte Immunity
Current Immunology Reviews (Discontinued) MMP Inhibitors in Cardiac Diseases: An Update
Recent Patents on Cardiovascular Drug Discovery Cellular Mechanisms of the Protective Effect of Polyphenols on the Neurovascular Unit in Strokes
Cardiovascular & Hematological Agents in Medicinal Chemistry Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Advances in Tissue and Organ Replacement
Current Stem Cell Research & Therapy Environmental Pollution and Diabetes Mellitus
Recent Patents on Biomarkers Editorial (Thematic Issue: Metabolic Syndrome in Pregnancy)
Current Pharmaceutical Biotechnology Dual Acting Anti-Inflammatory Drugs
Current Topics in Medicinal Chemistry